Loading, Please Wait...
BENTONVILLE, Ark., May 21, 2019 (GLOBE NEWSWIRE) -- -- via OTC PR WIRE -- Glucose Health, Inc. (OTC: GLUC) confirms the following selected financial data from its QUARTERLY REPORT for the period ended March 31, 2019, posted on OTCMarkets.com.
Quarterly period ended March 31, 2019:
1) Q1 Fiscal 2019 Revenue of $82,396 compared with $38,421 Revenue for Q1 Fiscal 2018; an increase of 114%.
2) Q1 Fiscal 2019 Gross Profit of $36,274 compared with $14,864 Gross Profit for Q1 Fiscal 2018; an increase of 144%.
3) Q1 Fiscal 2019 Total Operating Expenses of $22,084 vs. $22,975 Total Operating Expenses for Q1 Fiscal 2018; a reduction of 4%.
Murray Fleming, CEO of Glucose Health, Inc., stated, "GLUCODOWN® Diabetic Friendly Formula Tea Mix offers consumers more than great taste – it also offers product efficacy, quality ingredients and unparalleled value-for-money:
About Glucose Health, Inc. (OTC: GLUC)
Manufactured by Glucose Health, Inc. (OTC: GLUC), GLUCODOWN® is the premier functional tea beverage in the diabetic nutritional consumer category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic, by the Centers for Disease Control and Prevention.4 GLUCODOWN® is a unique and compelling functional beverage and the first tea mix enriched with healthy soluble fiber. Glucose Health, Inc. is a publicly-traded company with the ticker symbol (OTC: GLUC). GLUCODOWN® is proudly manufactured in the USA in Arkansas and Minnesota.
1,2For citations see www.glucodown.com/clinical-data
3$49.07 = (Amazon Survey 2018-11-15)
4National Diabetes Statistics Review, 2017; Centers for Disease Control and Prevention, Department of Health and Human Services.
Glucose Health, Inc.